Identification of a Common Different Gene Expression Signature in Ischemic Cardiomyopathy
- PMID: 29361784
- PMCID: PMC5793207
- DOI: 10.3390/genes9010056
Identification of a Common Different Gene Expression Signature in Ischemic Cardiomyopathy
Abstract
The molecular mechanisms underlying the development of ischemic cardiomyopathy (ICM) remain poorly understood. Gene expression profiling is helpful to discover the molecular changes taking place in ICM. The aim of this study was to identify the genes that are significantly changed during the development of heart failure caused by ICM. The differentially expressed genes (DEGs) were identified from 162 control samples and 227 ICM patients. PANTHER was used to perform gene ontology (GO), and Reactome for pathway enrichment analysis. A protein-protein interaction network was established using STRING and Cytoscape. A further validation was performed by real-time polymerase chain reaction (RT-PCR). A total of 255 common DEGs was found. Gene ontology, pathway enrichment, and protein-protein interaction analysis showed that nucleic acid-binding proteins, enzymes, and transcription factors accounted for a great part of the DEGs, while immune system signaling and cytokine signaling displayed the most significant changes. Furthermore, seven hub genes and nine transcription factors were identified. Interestingly, the top five upregulated DEGs were located on chromosome Y, and four of the top five downregulated DEGs were involved in immune and inflammation signaling. Further, the top DEGs were validated by RT-PCR in human samples. Our study explored the possible molecular mechanisms of heart failure caused by ischemic heart disease.
Keywords: bioinformatical analysis; ischemic cardiomyopathy; microarrays.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




References
-
- Ponikowski P., Voors A.A., Anker S.D., Bueno H., Cleland J.G., Coats A.J., Falk V., Gonzalez-Juanatey J.R., Harjola V.P., Jankowska E.A., et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Rev. Esp. Cardiol. 2016;69:1167. - PubMed
-
- Rouleau J.L., de Champlain J., Klein M., Bichet D., Moye L., Packer M., Dagenais G.R., Sussex B., Arnold J.M., Sestier F., et al. Activation of neurohumoral systems in postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol. 1993;22:390–398. doi: 10.1016/0735-1097(93)90042-Y. - DOI - PubMed
-
- Ripatti S., Tikkanen E., Orho-Melander M., Havulinna A.S., Silander K., Sharma A., Guiducci C., Perola M., Jula A., Sinisalo J., et al. A multilocus genetic risk score for coronary heart disease: Case-control and prospective cohort analyses. Lancet. 2010;376:1393–1400. doi: 10.1016/S0140-6736(10)61267-6. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources